Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 2
1959 1
1972 1
1973 1
1975 1
1976 1
1978 2
1979 3
1980 1
1981 1
1982 7
1983 5
1984 4
1985 2
1986 6
1987 8
1988 12
1989 6
1990 7
1991 19
1992 16
1993 18
1994 13
1995 21
1996 20
1997 26
1998 31
1999 45
2000 43
2001 57
2002 65
2003 58
2004 80
2005 103
2006 134
2007 165
2008 176
2009 228
2010 275
2011 317
2012 349
2013 447
2014 483
2015 531
2016 548
2017 603
2018 675
2019 766
2020 902
2021 1007
2022 1275
2023 1232
2024 1524
2025 756

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,627 results

Results by year

Filters applied: . Clear all
Page 1
High-throughput screening unveils nitazoxanide as a potent PRRSV inhibitor by targeting NMRAL1.
Cui Z, Liu J, Xie C, Wang T, Sun P, Wang J, Li J, Li G, Qiu J, Zhang Y, Li D, Sun Y, Yin J, Li K, Zhao Z, Yuan H, Bai X, Ma X, Li P, Fu Y, Bao H, Li D, Zhang Q, Liu Z, Cao Y, Zhang J, Lu Z. Cui Z, et al. Among authors: yuan h. Nat Commun. 2024 Jun 6;15(1):4813. doi: 10.1038/s41467-024-48807-y. Nat Commun. 2024. PMID: 38844461 Free PMC article.
The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial.
Cheang I, Yao W, Zhou Y, Zhu X, Ni G, Lu X, Liao S, Gao R, Zhou F, Shen J, Leung AYL, Jiang M, Kong H, Bai L, Mahemuti A, Yuan H, Dong YG, Wong CK, Xu Q, Zhang G, Wu J, Lu Q, Zhang J, Cha C, Ren Q, Fu L, Wang B, Xu Y, Hu H, Dong J, Shang Z, Yu C, Li S, Yao C, Gao L, Zhang H, Rosenzweig A, Jia Z, Li X; QUEST Trial Committees and Investigators. Cheang I, et al. Among authors: yuan h. Nat Med. 2024 Aug;30(8):2295-2302. doi: 10.1038/s41591-024-03169-2. Epub 2024 Aug 2. Nat Med. 2024. PMID: 39095596 Free PMC article. Clinical Trial.
Plin2-mediated lipid droplet mobilization accelerates exit from pluripotency by lipidomic remodeling and histone acetylation.
Wu Y, Chen K, Li L, Hao Z, Wang T, Liu Y, Xing G, Liu Z, Li H, Yuan H, Lu J, Zhang C, Zhang J, Zhao D, Wang J, Nie J, Ye D, Pan G, Chan WY, Liu X. Wu Y, et al. Among authors: yuan h. Cell Death Differ. 2022 Nov;29(11):2316-2331. doi: 10.1038/s41418-022-01018-8. Epub 2022 May 25. Cell Death Differ. 2022. PMID: 35614132 Free PMC article.
Pharmacological Properties of Ginsenoside Re.
Gao XY, Liu GC, Zhang JX, Wang LH, Xu C, Yan ZA, Wang A, Su YF, Lee JJ, Piao GC, Yuan HD. Gao XY, et al. Among authors: yuan hd. Front Pharmacol. 2022 Apr 6;13:754191. doi: 10.3389/fphar.2022.754191. eCollection 2022. Front Pharmacol. 2022. PMID: 35462899 Free PMC article. Review.
Immunotherapy for Pemphigus: Present and Future.
Yuan H, Pan M, Chen H, Mao X. Yuan H, et al. Front Med (Lausanne). 2022 Jun 15;9:901239. doi: 10.3389/fmed.2022.901239. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35783635 Free PMC article. Review.
SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis.
Qin C, Rao Y, Yuan H, Wang TY, Zhao J, Espinosa B, Liu Y, Zhang S, Savas AC, Liu Q, Zarinfar M, Rice S, Henley J, Comai L, Graham NA, Chen C, Zhang C, Feng P. Qin C, et al. Among authors: yuan h. Proc Natl Acad Sci U S A. 2022 Jun 28;119(26):e2122897119. doi: 10.1073/pnas.2122897119. Epub 2022 Jun 14. Proc Natl Acad Sci U S A. 2022. PMID: 35700355 Free PMC article.
11,627 results
You have reached the last available page of results. Please see the User Guide for more information.